Discovery and in Vitro Optimization of 3‐Sulfamoylbenzamides as ROMK Inhibitors

Discovery and in Vitro Optimization of 3‐Sulfamoylbenzamides as ROMK Inhibitors

Matthew F. Sammons, Sujay V. Kharade, Kevin J. Filipski, Markus Boehm, Aaron C. Smith, Andre Shavnya, Dilinie P. Fernando, Matthew S. Dowling, Philip A. Carpino, Neil A. Castle, Shannon G. Zellmer, Brett M. Antonio, James R. Gosset, Anthony Carlo, and Jerod S. Denton

View Publication